CardioScan

United Kingdom and international markets

Visit company website Open evidence source

Company profile

About the company

CardioScan provides cardiac monitoring analysis and related diagnostic technology for healthcare organisations. Its services support clinicians interpreting ambulatory heart data and managing diagnostic workflows. The company serves hospitals, clinics and medical partners in the United Kingdom and other markets through technology-enabled reporting operations.

Public claim

What the listing records.

“CardioScan commits to achieving net-zero greenhouse-gas emissions by 2050.”

Evidence note

The March 2026 UK Carbon Reduction Plan states the 2050 target, reports a 2023 baseline and records the company's SME Climate Hub commitment.

Source type: Company website